Published in Bioinformatics on December 10, 2015
Scalable molecular dynamics with NAMD. J Comput Chem (2005) 59.49
All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B (1998) 54.00
Canonical dynamics: Equilibrium phase-space distributions. Phys Rev A Gen Phys (1985) 26.82
Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods (2001) 7.08
ZINC: a free tool to discover chemistry for biology. J Chem Inf Model (2012) 6.57
Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun (1991) 3.25
Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol (2005) 3.00
Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev (2001) 3.00
ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov (2003) 3.00
A general purpose model for the condensed phases of water: TIP4P/2005. J Chem Phys (2005) 2.74
SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem (2011) 2.74
MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. J Pharm Sci (1999) 2.40
Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J Pharm Sci (1990) 2.04
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov (2010) 1.94
In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth. Pharm Res (1997) 1.84
Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm Res (1999) 1.70
ChemMine tools: an online service for analyzing and clustering small molecules. Nucleic Acids Res (2011) 1.56
Recent advances in computational prediction of drug absorption and permeability in drug discovery. Curr Med Chem (2006) 1.47
Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci (2000) 1.45
Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety. Chem Res Toxicol (2011) 1.35
The role of size and charge for blood-brain barrier permeation of drugs and fatty acids. J Mol Neurosci (2007) 1.31
Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability. J Med Chem (2005) 1.28
Correlating partitioning and caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharm Res (1998) 1.27
Current industrial practices of assessing permeability and P-glycoprotein interaction. AAPS J (2006) 1.23
Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter. Pharm Res (2000) 1.19
A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proc Natl Acad Sci U S A (1994) 1.14
Drug interactions with lipid membranes. Chem Soc Rev (2009) 1.13
pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions. Pharm Res (2003) 1.13
ADME evaluation in drug discovery. 5. Correlation of Caco-2 permeation with simple molecular properties. J Chem Inf Comput Sci (2004) 1.13
PAMPA--critical factors for better predictions of absorption. J Pharm Sci (2007) 1.10
Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharm Res (1998) 1.06
Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability. Bioorg Med Chem Lett (2009) 1.05
A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential. Eur J Med Chem (2002) 1.03
Strategies for absorption screening in drug discovery and development. Curr Top Med Chem (2001) 0.99
Transport of artemisinin and sodium artesunate in Caco-2 intestinal epithelial cells. J Pharm Sci (1996) 0.95
pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers. Eur J Pharm Sci (2005) 0.94
Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers. Eur J Pharm Biopharm (2002) 0.93
Influence of passive permeability on apparent P-glycoprotein kinetics. Pharm Res (2000) 0.91
Evaluation of Biocoat intestinal epithelium differentiation environment (3-day cultured Caco-2 cells) as an absorption screening model with improved productivity. Pharm Res (1997) 0.90
The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds. Pharm Res (2000) 0.89
ADME-Tox in drug discovery: integration of experimental and computational technologies. Drug Discov Today (2003) 0.85
Prediction of Caco-2 cell permeability using a combination of MO-calculation and neural network. Int J Pharm (2002) 0.85
Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption. Pharm Res (1996) 0.84
A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulations. Biophys J (2014) 0.84
Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption. Pharm Res (1993) 0.84
Hydration structure of the quaternary ammonium cations. J Phys Chem B (2010) 0.84
Prediction of membrane permeability to peptides from calculated dynamic molecular surface properties. Pharm Res (1999) 0.82
Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers. Pharm Res (2000) 0.81
Estimation of ADME properties in drug discovery: predicting Caco-2 cell permeability using atom-based stochastic and non-stochastic linear indices. J Pharm Sci (2008) 0.81
Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles. Mol Pharm (2011) 0.80
An improved cell culture model based on 2/4/A1 cell monolayers for studies of intestinal drug transport: characterization of transport routes. Pharm Res (2003) 0.79
In vitro intestinal permeability of factor Xa inhibitors: influence of chemical structure on passive transport and susceptibility to efflux. Pharm Res (2001) 0.78
In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery. Pharm Res (1993) 0.77
Kinetic characterization of secretory transport of a new ciprofloxacin derivative (CNV97100) across Caco-2 cell monolayers. J Pharm Sci (2002) 0.77
Drug delivery studies in Caco-2 monolayers. Synthesis, hydrolysis, and transport of O-cyclopropane carboxylic acid ester prodrugs of various beta-blocking agents. Pharm Res (1995) 0.77
Predicting Caco-2 permeability using support vector machine and chemistry development kit. J Pharm Pharm Sci (2006) 0.77
Drug permeability prediction using PMF method. J Mol Model (2012) 0.77
Mapping the hydropathy of amino acids based on their local solvation structure. J Phys Chem B (2014) 0.76